A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/50 (2006.01) A61P 9/04 (2006.01)
Patent
CA 2596768
The invention relates to intermittent administration of a levosimendan compound or a pharmaceutically acceptable salt thereof in the treatment of cardiovascular disorders such as chronic heart failure. The intermittent dose is more than 0.04 mg/kg and the period between each intermittent dose is 6 - 30 days, preferably 6 - 25 days. The administration is suitably an intermittent intravenous infusion.
La présente invention concerne l'administration intermittente d'un composé levosimendan ou d'un sel de celui-ci répondant aux normes pharmaceutiques dans le traitement de troubles cardio-vasculaires tels que l'insuffisance cardiaque chronique. La dose intermittente est supérieure à 0.04 mg/kg et la période entre chaque dose intermittente est de 6 à 30 jours, de préférence de 6 à 25 jours. Cette administration est judicieusement effectuée par voie intraveineuse de manière intermittente.
Orion Corporation
Robic
LandOfFree
A method for treating heart failure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A method for treating heart failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A method for treating heart failure will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2045798